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ABSTRACT
PREDICTIVE MODELING OF INFLUENZA IN NEW ENGLAND
USING A RECURRENT DEEP NEURAL NETWORK
by
Alfred Amendolara
Predicting seasonal variation in influenza epidemics is an ongoing challenge. To better
predict seasonal influenza and provide early warning of pandemics, a novel approach
to Influenza-Like-Illness (ILI) prediction was developed. This approach combined a
deep neural network with ILI, climate, and population data. A predictive model was
created using a deep neural network based on TensorFlow 2.0 Beta. The model used
Long-Short Term Memory (LSTM) nodes. Data was collected from the Center for
Disease Control, the National Center for Environmental Information (NCEI) and the
United States Census Bureau. These parameters were temperature, precipitation,
wind speed, population size, vaccination rate and vaccination efficacy. Temperature
was confirmed as the greatest predictor for ILI rates, with precipitation providing a
small increase in predictive power. After training, the model was able to predict ILI
rates 10 weeks out. As a result of this thesis, a framework was developed that may be
applied to weekly ILI tracking as well as early prediction of outlier pandemic years.
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CHAPTER 1
INTRODUCTION
Influenza virus is responsible for a recurrent, yearly epidemic in most temperate
regions of the world. According to the CDC, in the 2017-2018 season alone, influenza
virus was responsible for 79,000 deaths and nearly 1 million hospitalizations [4].
The disease burden of influenza is substantial. As a result of viral mutation, as
well as a variety of climate factors, seasonal trends can shift radically year to year.
This necessitates the development of a new vaccine for each season. Despite the
combined efforts of scientists around the world, vaccine efficacy is variable. In some
years effectiveness has been estimated as low as 20% [106, 10]. Additionally, severe
pandemics can occur with little warning. Most recently, the 2009 Swine Flu caused
an unusually long and deadly flu season [73]. Modeling and forecasting of influenza
is critical for predicting pandemics such as this.
This thesis will examine the structure, pathology, epidemiology, and evolution
of the influenza virus in order to apply machine learning techniques to produce
a forecasting model. First the structure of an individual influenza virus will
be discussed, followed by the genome, important protein components and viral
replication. Then the evolution of the virus. Next, the mechanisms of transmission
and infection, the clinical signs and the immune response will be examined. Finally,
this introduction will end with an overview of influenza epidemiology and applied
modeling.
The goal of this paper is to produce an effective predictive model that will shed
light on the factors that impact influenza seasonality as well as provide a functional
predictive model for real-time flu forecasting. Variables including temperature,
precipitation, wind speed, and vaccination rates were added to a deep recurrent neural
1
network. The network was built on TensorFlow 2.0 Beta using the Keras API. An
effective architecture was developed that provided robust predictions 1 week, 2 weeks,
and 3 weeks out, as well as a framework for recurrent predictions that could continue
on past several months.
2
CHAPTER 2
BACKGROUND
2.1 Structure and Replication
Since the discovery of the influenza virus, all the major components of the virus
have been examined. Given the seasonal nature of influenza and the potential for
major pandemics, there has been extensive research to elucidate viral structure and
proteins. This has allowed scientists to choose targets for antivirals. Additionally,
it has allowed epidemiologists to identify many viral subtypes. One example is the
H1N1 strain that was responsible for the 2009 Swine-Flu Pandemic.
This section will summarize the basic structure of an influenza virus, the
structure of the viral genome, the function of important proteins, and the replication
of the virus.
2.1.1 Morphology
Influenza belongs to the viral family Orthomyxoviridae. There are four subtypes of
influenza; A, B, C, and D. Influenza A is the most common type seen in humans and
will be the primary focus of this section as it accounts for the majority of seasonal
outbreaks and is more heavily studied. Influenza B is also regularly seen in humans,
but to a lesser extent than influenza A. Influenza C is rarely seen in humans and does
not generally contribute to seasonal influenza outbreaks. Influenza D does not occur
in humans and will be ignored completely [3, 63]. Unless otherwise noted, we will be
discussing influenza A.
Influenza is an enveloped, spherical negative-sense RNA virus approximately
100nm in diameter. It can also occasionally be filamentous. The influenza virus has
three major structural components: an envelope, a matrix directly beneath the lipid
bilayer, and ribonucleoproteins (RNP) in the center of the virus [63].
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Figure 2.1 Diagram of influenza virus.
The outer envelope is composed of a lipid bi-layer derived from the host cell
membrane. Lipid rafts containing neuraminidase (NA) float in a sea of hemagglutinin
(HA). Hemagglutinin, which makes up about 80% of membrane bound protein,
and neuraminidase, which makes up about 20%, are both important viral proteins
necessary for infection and replication [65, 59, 77]. M2, a viral proton pump, is also
embedded in small numbers in the envelope. The specifics of each of these proteins
will be discussed in more detail later. The next major structural component is the
matrix. The matrix exists directly beneath the envelope and serves to anchor NA,
HA, and RNP inside the virus. The matrix is also involved in viral budding. It is
made up of the matrix protein M1.
The inner most component of an influenza virus are the RNP. These are protein-
RNA complexes that contain the genetic material necessary for viral propagation as
well as various proteins. RNP are helical structures. In addition to the viral RNA,
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some nuclear export proteins (NEP) are present, as well as basic polymerase 1 (PB1),
basic polymerase 2(PB2), and acidic polymerase (PA) [65, 64, 77].
2.1.2 Genome
The genome of the influenza virus contains 8 segments of single stranded RNA.
Segment 1 encodes the various polymerase proteins and segments 2 and 3 encode
proteins involved in virulence modulation [101]. In influenza A viruses, the focus of
this section, segments 4, 5 and 6 code for hemagglutinin, nucleocapsid protein and
neuraminidase [101, 46]. Nucleocapsid proteins are bound to viral RNA and play a
role in viral genome replication [46]. Segments 7 and 8 code M2 along with nuclear
export protein and structural proteins [49]. These coding regions are flanked on both
5’ and 3’ ends by non-coding regions [46]
Figure 2.2 Genome of influenza A virus. This illustration shows the length of
each viral RNA segment in base pairs (BP) as well as the polypeptide product. The
genome of influenza B is similar in layout, but with different segment lengths [46].
The genome resides in the center of the virus particle. It is found in RNP
complexes with RNA polymerases and NP. Viral RNA (vRNA) is associated with NP
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in strands. The genome is replicated by polymerases PB1, PB2, and PA [46, 102].
First, the RNP complexes are into the cytoplasm of an infected cell. Then, within the
nucleus of the cell, viral polymerases replicate the vRNA [102]. This replication peaks
approximately two hours after infection and begins to decrease at approximately 3
hours after infection [75, 83]. After replication, vRNA joins with NP and forms RNP
complexes. These are transported out of the nucleus by viral NEP along with host
factors. They then move toward sites of budding where they will be incorporated into
new virus particles [69].
2.1.3 Hemagglutinin, Neuraminidase and M2
Hemagglutinin, Neuraminidase and M2 the the three surface proteins of the infleunza
virus. Hemagglutinin is the major surface protein of influenza viruses. It is primarily
responsible for binding sialic acid to allow entry into host cells [86]. It is a trimer
composed of triple stranded α-helices and anti-parallel β-sheets [100]. A highly
conserved region on the top of the HA molecule forms a depression where sialic acid
bonds to. Specifically, there are two major linkages to sialic acid that HA forms. These
are the α(2,3)-Gal and the α(2,6)-Gal linkages. Human viruses bind to α(2,6) while
avian viruses bind to α(2,3) [86]. Because of these differences in binding preference,
mutations must occur to allow inter-species transmission. Swine have both kinds of
receptors and provide a reservoir for these kinds of mutations. Generally antigenic
shift is prominent in the exterior, binding sections of HA, while distal sections tend
to be retained [99, 98]. In general, blocking HA using anti-HA antibodies effectively
neutralizes viral infectivity [99].
The other major surface protein found on influenza viruses is neuraminidase.
It is a tetramer composed of four identical sub-units [59, 94]. The main role of
neuraminidase is believed to cleavage sialic acid to release newly formed virus particles
from the cell surface after budding[58]. It also may allow the virus to escape capture
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in mucus through the same mechanism. Neuraminidase stalk length may play a role
in virulence as well, differing lengths have been shown to have differing levels of
infectious activity. This may be a result of occlusion of the active site if the stalk is
too short [66]. Additionally, neuraminidase ay be involved in infection of host cells.
Its active site is also highly conserved [7].
The last of the surface proteins is M2, an ion channel. It is an integral membrane
protein formed by a di-sulfide linked homotetramer [51, 88]. It tends to be present
in very low quantities, only 15-20 molecules may be on the surface of any given
virus particle [104]. Despite its low concentration compared to neuraminidase and
hemagglutinin, it is essential for replication as it facilitates uncoating. It is also
responsible for adjusting pH in the Golgi during viral replication [50, 79]. M2 may
also inhibit P58, aiding in immune response evasion [32].
2.1.4 Viral Replication
Viral replication begins after a viron binds to the sialic acid receptors of a target cell.
HA in particular is responsible for the binding of sialic acid (2.3.1). This triggers
receptor mediated endocytosis and the viral particle enters the host cell. In this
stage, M2 proton channels are responsible for lowing the pH of the endosome to
induce conformational changes in HA. Lowering the pH also prompts the release
of vRNPs into the cell [78]. These vRNPs can then enter the nucleus and begin
replication (2.3.3).
The various proteins that make up a RNP each have nuclear localization signals
that allow them to make use of cellular mechanisms for entry into the nucleus. Once
the a RNP is transported into the nucleus, viral RNA makes use of many existing
cellular mechanisms for replication. The negative sense vRNA is replicated by viral
RNA dependant RNA polymerases [78].
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Once replicated, negative sense vRNA is exported through nuclear pores to
form completed RNPs. Proteins necessary to form the RNPs are produced in the
cytoplasm. Surface proteins are produced in the ER and Golgi (2.3.4). Influenza
makes use of the host cell membrane to form its envelope. Once completed surface
proteins have been transported to the host membrane, RNPs are localized and bud off
in newly formed viral particles (2.3.5) [63, 78]. From here, viral particles can continue
the cycle of infection.
Nucleus
Cytoplasm
Figure 2.3 Influenza virus replication.
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2.2 Evolution
Influenza has almost certainly existed through human history and the earliest cases
may have been recorded by Hippocrates [57]. The disease was certainly known.
However, it was not until the 1930’s that the virus was isolated in pigs [84]. Even
with the advent of modern medicine, we are subject to regular, seasonal epidemics and
even occasional worldwide pandemics. Despite the creation of vaccines that wiped
out diseases like small-pox and polio and the advent of antiviral medication, influenza
has remained a constant burden. Influenza’s rapid mutation is largely responsible for
its ability to elude eradication [17].
2.2.1 Mutation and Antigenic Drift
Influenza virus has a high mutation rate, approximately 1.5x10−5 mutations per
replication cycle. This high mutation rate causes significant variability in the surface
proteins, especially hemagglutinin [70]. Increased variability inevitably leads to novel
viral subtypes which are able to escape immune detection. This process is called
antigenic drift. This unusually high rate of mutation is due to vRNA polymerase’s
lack of proofreading mechanisms [82]. Animals also almost certainly act as reservoirs
for influenza [96]. Notably, animals with both α(2,3) and α(2,6) linkages may act as
a type of melting pot that allows virus to undergo re-assortment. Re-assortment is
the exchange of RNA segments between genetically unique viruses [96]. For example,
the 2009 Swine Flu pandemic was likely caused by a single amino acid substitution
in the protein PB1-F2 [19]. Rapid recombination and re-assortment can result in an
even more rapid phenomenon called antigenic shift. Antigenic shift gives influenza
its ability to quickly jump between species and create novel strains [35].
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2.2.2 Influenza in Animals
Influenza is able to rapidly mutate and form novel subtypes. This allows seasonal
epidemics in humans despite advances in vaccines and antiviral medications. However,
influenza infects other animals as well. Notably, waterfowl and other aquatic birds
are widely affected [33]. Swine are also prone to infection. Horses and some other
animals may be infected as well but these infections are generally not transmissible
to humans [96]. On the other hand, birds and pigs often transmit novel influenza
strains to humans and act as long term reservoirs for subtypes [33, 96].
Aquatic birds and waterfowl acting as regular reservoirs has serious implications
for human health. Domestic birds may also carry influenza. In many cases, all of
these birds are asymptomatic. Generally, the receptors for bird influenza strains exist
in the intestine. The virus may then be transmitted by fecal matter and in water.
Ducks, for example, shed the virus heavily. A large percentage of the populations
of waterfowl, especially juvenile birds, may be infected year round [97, 33, 96]. The
permanent reservoir which birds provide influenza allows inter-seasonal mutations
and the reemergence of viruses that had otherwise disappeared in humans.
Pigs may provide a similar environment for influenza virus. Pigs, uniquely, have
both avian and human receptors. As such, they are able to act as an effective bridge
between avian and human influenza [85]. In order for influenza to leap from birds to
humans, mutations must occur on the binding sites of hemagglutinin. However, since
swine can be infected with both human and avian strains, rapid antigenic shifts can
occur [96]. This can promote the formation of novel combinations of surface proteins.
This, by extension, can lead to pandemic strains of influenza since no prior immunity
exists in human populations.
Aside from birds and pigs other animals may become infected with influenza.
Generally they are not of concern to human populations. However, animals provide
useful models for studying influenza. Many of the studies examining influenza
10
transmission, vaccines and pathogenesis use guinea pigs or ferrets as model organisms
[11].
2.3 Pathology
The pathology of influenza is well documented. The disease is an upper respiratory
infection that lasts several weeks and is not usually life threatening. Most cases are
clinically diagnosed, meaning they are made in the absence of laboratory testing.
A combination of the time course, context and symptoms are used by physicians
in outpatient settings to estimate influenza infections [61]. The CDC and WHO
suggest using masks, washing hands and regularly disinfecting surfaces [6, 5]. Non-
pharmaceutical interventions are also attractive and widely used since they cost less
than antivirals and take less time to distribute than targeted vaccines. However,
their efficacy is debated and not enough is known about the mechanisms of influenza
transmission to make absolute recommendations [43, 13].
2.3.1 Mechanisms of Transmission and Infection
The mechanism of influenza transmission between individuals is of great importance in
an epidemic or pandemic. The question of how best to prevent spreading of infection
is difficult to answer. There are three main ways by which influenza virus may be
transmitted. One, direct contact between an infected individual and a non-infected
individual. This may be through shaking hands or other direct touching. Secondary
contact via some surface such as a door knob may also play a role [47]. Two, large
droplets may carry influenza virus. These droplets can be expelled by an infected
person while coughing or talking. However, these large droplets generally fall out of
the air after about 1m [47, 43]. Three, small aerosol droplets, generally defined as
< 5µm, may be expelled by infected patients [16, 48, 47]. These small particles are
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likely the primary source of infection as they remain airborne for the longest time
and are able to reach the lower respiratory tract [47].
Large droplets and aerosols are not distinct categories, however. Classification
is based on size and droplets exist across a spectrum with distinctions between the
categories blurring towards the center. In fact, as liquid evaporates, large droplets
may become smaller aerosol particles mid-air. A significant number of infected
patients expel viable amounts of viral material when coughing or speaking [52].These
droplets can also be propelled across the room [48]. Mere proximity to an infected
individual does not guarantee transmission though. Both aerosol and large droplets
are important in transmission of virus, but they each face challenges entering the
body.
Airborne virus, whether in large droplets or small aerosol particles must reach
vulnerable tissue. Large droplets may contain more virus and that virus may be better
protected from the environment. However, large droplets generally do not pass the
upper respiratory tract. There, thicker mucus necessitates large amounts of viable
viral material to infect cells [47]. Aerosols, on the other hand, may not contain as
much viral material or be able to survive as long. They can infect lower respiratory
epithelium, though. Additionally, they may be able to travel several meters away and
remain suspended in the air for much longer [43, 47, 48, 92].
Once viable viral material reaches susceptible tissues in the respiratory tract,
it is able to replicate [103]. From there, the virus spreads and causes the mild to
moderate upper respiratory symptoms influenza is known for. In order to then infect
a new host, the virus must be transmitted in one of the ways discussed. An infected
patient sheds viral material for approximately 3 days. This shedding may begin prior
to onset of symptoms. Additionally, younger children shed significantly longer than
older children and adults [67].
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2.3.2 Clinical Signs and Symptoms
Once a patient is infected with influenza, some time may pass prior to displaying
symptoms [67, 103]. This is an important consideration when observing transmission
and incidence rates, as a patient may spread the virus prior to displaying clinical
symptoms and may delay seeing a doctor for several days after infection. Delayed
reporting can create a lag in observed incidence levels.
After the appearance of symptoms, the illness can last for several weeks.
Generally they are mild and not life threatening [5]. However, a large portion of
hospitalizations and deaths occur as a result of co-infection with bacterial illness
such as pneumonia [24]. In fact, many of the deaths during the 1918 Spanish Flu
were caused by bacterial co-infections [62]. Most cases of influenza do not require
hospitalization and are clinically diagnosed [5, 61]. Symptoms are variable and are
generally similar to other upper respiratory infections (Table 2.1). Thus, accurate
clinical diagnosis has an direct impact on ILI rates.
2.4 Immune Response
The respiratory tract is the main point of entrance for influenza viruses. The
virus is able to infect upper and lower respiratory tissue, initiating innate and
adaptive immune responses. Dendritic cells are the primary innate immune mediator,
recognizing viral particles [12]. The adaptive immune response is handled by effector
T cells responding to viral antigens. These cells are responsible for balancing adaptive
responses as well as regulating the inflammatory response [12]. Both innate and
adaptive immune responses are important for viral clearance and provide immunity
to re-infection.
2.4.1 Innate Immunity
The first line of defense to influenza, and most other diseases, is the innate immune
system. Given that influenza is a respiratory illness in humans, our focus will be on
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Table 2.1 Common Influenza Symptoms and Their Clinical Frequency.
[61, 6]
Symptoms Clinical
Frequency
Description
(i) weakness 94% generalized fatigue and lack
of strength
(ii) myalgia 94% muscle pain or soreness
(iii) cough 93% usually a hacking, dry cough
(iv) nasal congestion 91% “runny nose” and clogged
sinuses
(v) subjective fever 90% feeling feverish without a
measurement of temperature
(vi) objective fever 68% measured temperature of
above 38 ◦C
(vii) loss of appetite 92% reduced desire to eat
(viii) headache 91% generalized pain to any region
of the head
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the barriers and responses present in the upper and lower respiratory tracts primarily.
Before infection can begin, influenza must travel into the body through the mouth
or nose. From there, it can move to the upper or lower respiratory tract and infect
epithelial cells. These cells are not defenseless though. The first barrier to infection is
the layer of mucus that constantly coats the respiratory tract. This mucus is rapidly
cleaned and replaced. It captures and flushes out influenza, along with other invaders,
sending them down the esophagus and into the stomach. Here strong stomach acid
destroys most bacteria and viruses [18]. However, as noted earlier, neuraminidase
may be responsible for helping viruses avoid becoming trapped in mucus layers.
Once cells are actually infected, vRNA may be recognized by pattern recognition
receptors or type 1 interferons which may promote cytokines and IFN-stimulated
genes [39]. Cytokines promote a variety of systematic and local immune responses,
including promoting inflammation. Additionally, cytokines recruit non-specific
immune cells such as macrophages and phagocytes to clear infected cells [39, 34].
IFN-stimulated genes produce a variety of proteins that aid in defense [39]. One
example is Myxovirus resistance protein 1 (MxA) which is the product of MX1
and may help prevent nuclear import of viral components [36]. Another example
is Interferon-induced transmembrane protein 3 (IFTM3) which inhibits viral release,
preventing new viruses from infecting more cells [14]. Finally, Tripartite motif-
containing 22 (TRIM22) protein targets viral nucleocapsids for degredation [22].
While the innate immune response plays an important role in preventing and
eventually eliminating infectious agents, it may have negative effects as well. Influenza
is noted to cause a variety of systematic symptoms [61]. However, influenza is not
a systematic illness. In extreme cases the immune response to viral infection can be
harmful. And in some cases, increased host response to infection can lead to increased
disease severity and mortality [72].
15
2.4.2 Adaptive Immunity
While the innate immune system hinders the influenza infection, the adaptive
immunity is responsible for clearing the body and preventing reinfection. There are
two primary adaptive immune responses, the humoral and the cell response. Both
play an important role in fighting viral infection.
The humoral response to influenza is mediated by B-cells. These B-cells produce
antibodies that primarily target hemagglutinin and neuraminidase [45]. Anti-HA
antibodies bind to the active site of HA and prevent attachment to sialic acid. This
results in inhibition of viral attachment to host cells. Anti-neuraminidase antibodies
limit viral spread by preventing sialic acid cleavage by neuraminidase. There are also
M2 specific antibodies that have been shown to effect virulence [45].
The primary classes of anitbodies responsible for anti-influenza activity are
IgA, IgM and IgG. These are common mucosal and serum antibodies [91]. These
antibodies, and the B-cells responsible for producing them, are what allows seasonal
influenza vaccines to be effective. The cell mediated response relies on CD4, CD8 and
regulatory T-cells [91, 45]. Notably, cytotoxic T-lymphocytes eliminate infected cells
[12].
2.5 Epidemiology
Seasonal influenza is a constant concern despite modern advances in vaccines and
antiviral medications. Influenza tends to spread rapidly and it is especially potent
during the winter when people tend to be in close contact indoors. So, unsurprisingly,
seasonal epidemics occur in the late fall through early spring [5]. Patterns form year
to year and are of importance to healthcare professionals trying to develop vaccines
and prepare for potential pandemics.
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2.5.1 Seasonal Influenza
Seasonal influenza creates a regular, repeating pattern from year to year. Influenza
cases begin to rise in October, peak in January or February, and trail off into April.
A close-up of the 2013-2014 influenza season can be seen in Figure 2.4. The regular
Figure 2.4 Graph of 2013-2014 influenza season ILI reveals winter peak. 2013-2014
was a typical flu season. ILI incidence rises slowly through October and November,
tipping over the regional baseline at week 50 of 2014. The season peaks shortly after
and the dips below the baseline again in April at week 17 of 2015.
nature of influenza epidemics is only surface deep, though. While the general pattern
remains similar year-to-year, there exists substantial variation. This variation can
be clearly seen in Figure 2.5. Years differ in overall incidence, peak, onset, and
end. Notably, pandemic years such as the 2009 Swine Flu may be significantly
different from the norm. Pandemic years in general are characterized by increased
virulence, disproportionate effects on the young and elderly, and summer illnesses
[62]. Attempts to model the yearly variation have been met with varying success.
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Figure 2.5 Weekly ILI from 2003 to 2018 reveals regular, repeating outbreaks.
Peaks influenza incidence occurs each year during winter months. The exception is
the 2009 flu season, now known as the Swine Flu pandemic, which can be found
centered at approximately week 300. This pandemic season was unusual in that ILI
incidence remained elevated through the spring and summer.
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There is no firm consensus on what causes the seasonal variability, but temperature,
dry air, and host immune irregularities may play a role [89, 25, 54]. People generally
spend more time indoors during colder weather and are therefore in regular close
contact. School closures, for example, are correlated with reduced ILI incidence,
suggesting that close proximity of infected and susceptible individuals is a driver for
seasonal spikes in influenza incidence [40]. Additionally, despite prior exposure, novel
viruses emerge that can evade host immune responses. This further increases yearly
variability [54]. Ultimately, yearly variability may be due to very small changes in a
multitude of variables that are amplified by population dynamics [23]. Interestingly,
tropical regions do not show strong seasonality. Instead they have generally flat ILI
incidence that varies with rainy season [89, 90].
2.5.2 Pandemics
While seasonal influenza epidemics are relatively predictable in many aspects, the
threat of novel sub-types emerging is constant. Influenza’s rapid mutation rate,
combined with persistent infection in reservoir species such as waterfowl and swine,
allows it to outpace host immune response. Influenza pandemics caused by novel
viruses occur irregularly and are difficult to predict. Early prediction is critical
to preparation and vaccine development, though. A rapid response can drastically
reduce disease burden and prevent excessive mortality.
Most notable of these pandemics was the 1918 Spanish Flu. The exact origin of
the H1N1 influenza that caused this pandemic is not known, but it likely moved from
swine to humans [42]. This was an especially virulent disease that disproportionately
affected young, healthy individuals [62]. Its virulence was likely caused by a single
mutation of PB1-F2 [19]. Over the course of the pandemic, the Spanish Flu was
responsible for an estimated 40-50 million deaths worldwide. Most of these deaths
were probably a result of bacterial co-infection, though [30].
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Other pandemics of the 20th century include the 1957 H2N2 Asian Flu and the
1968 Hong Kong Flu [42]. Most recently, the 2009 pandemic emerged as a result of a
novel H1N1 virus. It was notable for increased virulence and disproportionate effects
on the elderly and children. The disease was generally mild but there was potential
for serious complications [73, 29]. A targeted vaccine was rushed out in record time
during the 2009 pandemic. The vaccine had a significant impact [31]. Additionally,
vaccines that contained the same H1N1 continued to be effective several years after
the pandemic [27]. These facts reinforce the need for early predictions of pandemics
and emphasize the effect a timely response can have.
2.5.3 Vaccines
Vaccination is a critical preventative measure that is useful during regular seasonal
flu seasons as well as during pandemics. Because of antigenic drift in the influenza
virus, new vaccines must be developed yearly [71]. These vaccines have effectiveness
rates that range from 10% to 60% [10, 93]. Vaccine effectiveness is extremely variable
and illustrates the difficulty in predicting relevant strains (Table 2.2).
Targeted vaccines were effective during the 2009 Swine Flu pandemic in the
United states [31]. However, strain-specific vaccines are not a practical defense
against pandemics [71]. Generally pandemics are sudden and unexpected. Thus,
targeted vaccines need to be developed rapidly and may be released significantly
after a pandemic begins.
2.5.4 Climate and Other Driving Factors
Seasonal variations in influenza are difficult to predict. The driving factors for yearly
differences in incidence rates are not well understood [89]. No true consensus exists on
the effect of individual climate variables, or other non-climate variables [80]. However,
given years of research, there are several strong candidates for seasonal drivers of
influenza.
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Table 2.2 Vaccination Rate and Effectiveness Varies Considerably From 2003-2018.
Vaccination rates calculated from data available on CDC FluVaxView [1].
Influenza Season Vaccine Effectiveness (%) Vaccination Rate (%)
2017-2018 38 [76] 55.0
2016-2017 40 [26] 41.7
2015-2016 48 [41] 46.8
2014-2015 19 [106] 45.6
2013-2014 52 [27] 47.1
2012-2013 49 [60] 43.7
2011-2012 47 [68] 42.1
2010-2011 60 [93] 39.2
2009-2010 56 [31] 38.8
2008-2009 41 [1] 34.2
2007-2008 37 [9] 31.7
2006-2007 52 [10] 28.7
2005-2006 21 [10] 25.6
2004-2005 10 [10] 20.0
2003-2004 52 [2] 12.7
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The most strongly correlated climate variable in temperate regions is temperature
[56]. Lower temperatures in particular may drive behavior that can increase flu
transmission, such as close contact and recirculated air [56]. However, temperature
itself may contribute to increased viral survivability and prolonged shedding [55].
Humidity, which also may affect viral survivability, shows up as a consistently
good predictor in a variety of scenarios in both temperate and tropical regions [21, 81,
90]. Humidity combined with temperature may both be strong drivers as close contact
during winter, and other non-climate explanations, may not be sufficient. Close
contact during summer months does not produce influenza epidemics in temperate
regions [20]. Secondary to humidity is precipitation, which is a strong predictor in
tropical regions [21].
Additionally, low UV index may contribute to seasonal trends [38]. This may
be in large part due to the role of vitamin D in the immune system. Vitamin D is
produced via sun exposure and a lack of vitamin D may result in immune deficiencies.
UV index alone is a strong enough predictor to explain many variations in seasonal
epidemics [15].
Overall there are a large number of factors, more than have been covered in this
section, that contribute to seasonal epidemics. Variation from year to year is difficult
to predict as no consensus on the underlying mechanisms of seasonal influenza exist.
In all likelihood, variation in seasonal trends may be the result on minute changes in
one of many factors. Given previous research, temperature, humidity and UV index
provide the best predictors to influenza rates. However, the underlying mechanisms
that create these correlations are not understood at this time.
2.6 Modeling
Influenza is a seasonal disease and almost guaranteed to regularly affect millions.
Providing hospitals and public health professions ample time to prepare is critical
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to mitigating the impact of flu seasons. Given the complex nature of the variables
involved in yearly variation, and the poor understanding of the underlying mechanisms,
a wide variety of models have been produced. These models seek to forecast
everything from broad yearly trends to granular incidence data.
Notably, each year the CDC holds a competition to forecast influenza seasons.
The challenge involves predicting 4 weeks out from reported flu incidence, predicting
peak week, peak intensity and onset week. A variety of models have been submitted.
Models include classic mechanistic models based on SIR (susceptible, infected,
recovered) as well as statistical models based on machine learning. Many models use a
combined approach for predicting various portions of the challenge. In general, these
models predict one week better than the CDC historical average, but the predictive
effectiveness falls off towards four weeks [74].
2.6.1 Modeling Approaches
Two basic approaches exist for modeling diseases. A mechanistic approach seeks
to break disease transmission into discrete segments that can be manipulated and
combined to produce accurate reproductions of disease dynamics. In general, mecha-
nistic models are based on biological principles and explain underlying mechanisms
[74]. Some examples include a 2013 study that models flu trends in Israel. The
model is a modified SIRS (susceptible, infected, recovered, susceptible) model and
basic climate and viral evolution factors. It successfully models general trends [8].
Another model making use of a modified SIRS model was able to predict more
granular data out to 7 weeks [80]. Mechanistic models such as these can provide
insight into the mechanisms that drive a biological process. However, they struggle
to model phenomenon that are not well understood. As mentioned in the previous
section, there is no consensus on the driving factors affecting seasonal flu.
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The alternative approach, statistical modeling, is better able to handle underlying
uncertainty. Statistical approaches to modeling are based on observations and raw
data. Predictions are made based on statistical trends. In many cases, machine
learning is applied. This approach can allow the model to detect trends not readily
understood or view-able by the designers of the model. Unfortunately, statistical
models provide no explanation of the underlying mechanisms [74]. A variety of
techniques exist in this category. ARIMA (Auto-Regressive Moving Average) may
be applied to flu data, as was in a 2010 study that explored climate variables and
time-lag effects [87]. SARIMA, or seasonal ARIMA, was also a common technique in
the CDC challenge [74]. Machine learning can also be readily applied for predictions.
A 2019 study used Random Forest modeling to evaluate climate factors including UV
index [38].
2.6.2 LSTM and Neural Networks
One machine learning approach that has gained popularity in recent years is LSTM
or Long-Short-Term-Memory. This technique, when applied to influenza, performed
better than random forest regression, support vector machines and ARIMA [105].
LSTM based neural networks have been used to assess social media data for flu
prediction [95]. LSTM based neural network models are only beginning to be applied
to influenza trend prediction [53].
LSTM based neural networks provide some distinct advantages over other
types of neural networks, which themselves provide advantages over other predictive
techniques. Neural networks are structured as an interconnected network of nodes
called neurons. These neurons represent self-contained sets of algorithms that output
values based on their input. Neural networks allow models to learn vast amounts of
data and detect patterns that would be otherwise impossible to extract. Two main
types of neural networks exist, feed-forward and recurrent. In feed-forward networks,
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the output of the previous node is feed into the next node. In recurrent networks,
time series data may be used, as results are fed back to previous nodes [44].
LSTM nodes were designed to allow for time-series forecasting. Specifically,
they seek to solve the problem of disappearing or exploding gradients that is common
in recurrent neural networks [28]. Gradients are an integral part of neural networks,
they affect the ”on/off” signals of the individual nodes. Depending on the data set and
hyper-parameters of the model, gradients can produce NA values. Essentially they
run out of bounds. LSTM nodes circumvent this problem by introducing a CEC or
constant error carousel [37]. The CEC allows for gradients to remain unchanged from
one node to the next. The more recent addition of a ”forget gate” allows the LSTM
node to reset, further reducing gradient runaway [28]. The basic structure of an LSTM
as implemented in Keras includes a forget gate, and input gate and an output gate
(2.6). LSTM based neural networks allow for complex time-series forecasts. They are
an ideal candidate for influenza prediction and provide a relatively novel foundation
for forecasting.
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Figure 2.6 LSTM solves the problem of disappearing gradients by implementing
a CEC and a forget gate. LSTM nodes contain a forget gate, an input gate and
an output gate. This architecture seeks to mitigate the effects of disappearing or
exploding gradients. σ denotes a hard sigmoid function, tanh denotes a hyperbolic
tangent function. X and + denote a multiplication and addition process, respectively.
Ct-1 is the memory from the previous LSTM node. Ht-1 is the output from the
previous node. Xt is the input.
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CHAPTER 3
MATERIALS AND METHODS
In this following two sections, the data acquisition process and the model building
process are detailed. Supplemental information on the data sets used is available in
the appendix. Additionally, select code segments are available for review. All code
related to the models may be found online. Data was processed in MiniTab and
R. Final data manipulation was done using Python. The models were designed and
constructed in Python using TensorFlow 2.0 BETA and the Keras API. TensorFlow
used GPU acceleration. The computer specs used to run the models are: Intel i7-3829
@ 3.60GHz, 64GB DDR3 RAM, RTX 2080 Ti 11GB.
3.1 Data Compilation
A source of data on influenza trends was identified. The Center for Disease Control
collects data from public health labs and private doctors offices. This provided the
most consistent data spanning 2 decades. The CDC posts weekly ILI rates and has
weekly records from 1998. This data is provided on a national level, in some cases a
state level and a regional level. In order to narrow the focus of this paper, the CDC
region 1 New England was chosen. It has distinct seasons, relatively uniform climate,
it is geographically continuous and climate data is readily available. Additionally,
it has continuous data from at least the 2003-2004 season. New England, for the
purposes of this paper, contains Maine, Connecticut, Rhode Island, New Hampshire,
Vermont and Massachusetts.
Once New England was selected, the initial data set from the CDC Flu View
was downloaded as a Comma-Separated-Values file. This set contained ILI percents,
total patients, and information on sub-typing. More information on this data, and a
sample can be found in the appendix. The data was imported into R. Data ranged
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from week 40 of the 2003-2004 flu season to the current 2018-2019 week. The data
was trimmed to include up to week 21 of the 2017-2018 season.
In addition to the raw data, the CDC calculates a regional base line for each year.
This baseline is calculated by taking the mean percent ILI for non-influenza weeks
from the three preceding seasons and adding two standard deviations. The CDC
defines a non-influenza week as periods of two or more consecutive weeks in which each
week accounted for less than 2% of the seasons total number of specimens that tested
positive for influenza in public health laboratories. This data was available from the
2007-2008 season onward. In order to fill in missing baselines for the previous several
seasons (from the 2003-2004 season to the 2006-2007 season) the CDC procedure was
followed as close as possible. Beginning with the 2003-2004 season, a 1 year baseline
was calculated since years prior to 2003 did not report off season ILI levels. Then the
next year had a 2 year baseline and so on until a full three year baseline was available.
The estimated baselines were adequate for the purposes of this model. All data was
weekly. A total of 816 weeks were used.
After acquiring flu data parameters were chosen. A set of climate, population,
and epidemiological factors had to be identified. An informal survey of recent papers
addressing the effect of climate on seasonal influenza trends was conducted. From this,
several promising climate variables were compiled. Temperature, humidity and UV
index were best correlated with influenza trends and were supported by a multitude
of studies. A 2016 study on influenza trends in the tropics further supported a link
between humidity and influenza outbreaks. El Nino years also showed higher than
usual influenza activity. A 2013 study conducted on data from Israel indicated that
along with climate, incorporating antigenic drift and immunity loss increased accuracy
of multi annual influence forecasting. From the available literature a list of potential
climate variables was compiled.
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In addition to climate factors, population density, travel patterns, and time
spent indoors were identified as potential drivers. Heating day and cooling day count
was used to represent time spent indoors. Heating days specifically is defined as any
day below a set temperature, usually 65 C. This is an industry measure to estimate
heating costs, but might also provide a proxy for cold days when people are more
likely to spend time indoors. Once these initial parameters were identified, dthe
climate data was accessed.
Climate data was taken from the National Oceanic and Atmospheric Administrations
Climate Data Online. In order to provide a sample representative of the region,
a single monitoring station was selected from each state for a total of 6 weather
stations. These stations include Hartford Bradley Airport, Connecticut; Boston,
Massachusetts; Augusta Airport, Maine; Mt. Washington, New Hampshire; Providence,
Rhode Island; Montpelier, Vermont. Most data was available as daily averages. Some
data was only available as monthly averages. All data was converted to weekly data
and trimmed to match the CDC data already collected. The mean of each weeks data
was then calculated to produce regional weekly data, which was included in the final
data set. The climate factors used were: average temperature, average wind speed
and precipitation.
In addition to the climate data, population data was taken from the U.S. Census
Bureau. This data included population totals and immigration data. This data was
added to the master sheet.
Finally, vaccination data was taken from the CDC. Vaccination rates were
collected on a regional bases from the CDC website. Estimated vaccine effectiveness
was extracted from the CDC website as well as scientific papers. See the appendix
for more details.
The final data set was limited to data that was available regionally on a
consistent basis. The only major missing climate data that was estimated was
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wind speed from Rhode Island. Missing data was filled in with average data from
the previous 10 years. The tail of the actual data set used is available to view in
the appendix. Due to availability constraints some promising parameters were not
included. These parameters were UV index, absolute humidity, El Nino, population
density and regional travel.
3.2 Building the Model
The master data set was then prepped for input into a model. Data originally
organized in a simple dataframe. However, in order to allow use of various node
types, the data was reshaped into a 3 dimensional array. The data was ultimately
broken into time-steps that represented 1 weeks data. Prior to reshaping, data was
standardized using the following equation:
(x−mean)
standard deviation
Once the data was reshaped and standardized, it was broken into training and testing
sets. In order to make the best use of limited data, several configurations were used.
The data was split into a variety of segments that were then used to train and test
the model in order to ensure generalizability. The data splits can be seen in Figures
3.1, 3.2 and 3.3.
Because of the time factor the data was not shuﬄed when training and testing.
However, separate models were trained and tested on shuﬄed data to determine a
random baseline and act as comparison. Select code segments can be found in the
appendix.
Once the data had been prepped, the actual model design began. In order to
develop a baseline for comparison, a simple deep neural network was constructed.
All specific model architectures used are explained in detail in the appendix. This
initial model predicted weekly ILI. Initially, the model was fed only influenza data.
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Figure 3.1 Data split into 270 week segments. The data was split into 2 sets of
270 weeks and one set of 266 weeks. The model was trained on 2 sets and tested on
1, with the training and testing sets rotated for each trial.
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Figure 3.2 Data split into 400 week training sets. The data was divided to allow a
400 week training set. The training set was then shifted to evaluate generalizability.
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Figure 3.3 Data split 700 week training sets. The data was divided to allow a 700
week training set. The training set was then shifted to evaluate generalizability.
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Other parameters were added individually to asses impact on accuracy. Mean square
error and mean absolute error were used as metrics to determine model accuracy and
control learning. In this first model, 3 dense layers using Rectifier linear unit (ReLU)
algorithms were implemented. The ReLU formula is defined as:
y = max(0, x)
By continually adding parameters, the most effective predictors could be identified.
A reduced data set was then compiled and a new model was designed.
The second iteration of the predictive model relied on time-series forecasting
to predict ILI rates one or more weeks in advance. In order to test features of the
model, only two layers were implemented to begin with. An input layer containing
a long-short term memory (LSTM) layer with 4 nodes and an output dense layer
with a single node was used. These nodes used the default hyperbolic tangent (tanh)
activation and hard sigmoid recurrent activation, shown below:
Hyperbolic Tangent : tanh(x) =
sinh(x)
cosh(x)
Hard Sigmoid : max(0,min(1, x ∗ 0.2 + 0.5))
From there, nodes and layers were added incrementally until gains slowed. Initially,
only 1 week was predicted. However, a function that looped predictions was written
to allow recurrent predictions to be made. Thus from this point on, the model was
able to predict further than 1 week into the future.
The final iteration of the model (3.5) was a recursive deep neural network made
up of a bidirectional LSTM input layer, two bidirectional LSTM hidden layers (3.4)
and a dense output layer with variable output nodes .
This model was tuned incrementally to achieve the best predictions. In order
to achieve the best performance.
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Figure 3.4 Bidirectional LSTM layer diagram.
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Input Layer Hidden Layers Output Layer
LSTM LSTM LSTM Dense
(270, 1, 13)* (5)**
500 500 500 5
Figure 3.5 Final model architecture. The final model contained 4 layers total. An
initial 500 node LSTM input layer with a variable shape, 2 hidden LSTM layers with
500 nodes each and a dense output layer with a variable output shape.
* the input shape varies with data shape
** output shape varies with label shape
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Once satisfactory base performance was achieved, comparisons were made
between training sets to confirm generalizability of the model, as well as identify
any potential data leaks. Then, a comparison of two different predictive methods
was made. One model predicted to out to 10 weeks automatically. The other model
predicted out to 1 week and recursively predicted the next 10 weeks using the function
mentioned early. Details of this function can be found in the Appendix. A comparison
of various time lags ranging from t - 1 to t - 52 was made.
Individual climate and population variables were also evaluated. After evaluation,
any variables found to negatively impact performance were removed from the data
set. The resulting data set will be referred to as the reduced data set as opposed to
the full data set that includes all data.
3.3 Predicting Outliers
Two models of identical architecture were trained on different data sets. The first
model, called Pincluded, was trained on the reduced data set containing all weeks from 0
- 540. The second model, Premoved, was trained on the same time span, except outlier
years were removed. Outlier years were chosen based on standardized percent ILI. Any
year with a standardized percent ILI above 4% was removed from the training date.
Both models were then tested on weeks 541 - 806. Divergence between predictions
was then used to extract a signal indicating an outlier year.
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CHAPTER 4
RESULTS
Predictions were made for tests sets of various lengths and frames. Baseline
performance was determined, then the most effective time lag was selected, and finally,
the data set was evaluated. Overall performance for each model was established using
absolute mean error (MAE), mean error, standard deviation, and visual analysis.
Week 1 predictions were the most accurate. Predicting further than 5 weeks was
influenced heavily by time lag, modeling method, and data selection. The most
significant increases in performance were achieved by tuning the time lag and by
using the recursive prediction function. The model was applied to outlier prediction
by combining the outputs of two identical models trained on differing data sets. This
multi-model approach was able to detect a weak signal preceding an outlier year.
4.1 Determining Baseline Performance
Once a functional model was created, baseline performance and generalizability were
evaluated. Using the complete data set and a time lag of one week, nine different
training sets were used to train models. These training sets were divided into three
groups of 400 week training sets, 540 week training sets and 700 week training sets.
MAE was used to determine relative performance along with visual interpretation of
predictions. MAE was recorded for weeks 1, 5 and 10 (4.1). The best performance
was achieved when predicting one week in advance. Both MAE and the standard
deviation of the error rose substantially by week 10. Two sample t-tests were used
to determine significant differences between week 1 predictions from each training
set. There was significant difference between different frame shifts within all three
training-set-length groups. The mean increase in MAE from week 1 to week 10 was
0.412. There was no significant difference between the 540 and 700 week training sets,
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although the 400 week training set performed significantly worse. Moving forward,
540 week training sets were used for testing as they provided sufficient predictive
ability and were easier to manipulate.
In general, model performance degraded as prediction week increased. Additionally,
the model consistently under-predicted values at weeks 5 and 10 (4.1). As true percent
ILI values tended towards high values, the model also consistently under-predicted.
The presence of extreme outliers in the test set, notably the 2009 Swine Flu pandemic,
reduced predictive performance and resulted in under-prediction.
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Figure 4.1 Prediction accuracy degrades as prediction time increases as well as
in the presence of outliers. 1 week predictions have the highest accuracy. When
predicting out to 5 and 10 weeks, predictions are worse, especially at extreme values.
Predicting an set containing the major outlier year, 2009 Swine Flu, accuracy degrades
(C). The recursive model with a 4 week time lag was used. Three versions were trained
on weeks 0–540, 270–806 and 0–270 and 540–806 weeks. A, B and C depict predicted
vs true percent ILI for each training set, respectively. Panel C shows predictions from
the test set containing the 2009 Swine Flu pandemic. All values are percent weighted
ILI.
4.2 Evaluating Variables
To fine tune the model and obtain the best predictions possible, climate and
population variables were evaluated. Prior to this, the complete data set was used
to make predictions. In order to determine how the variables may be effecting
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Table 4.1 Mean Absolute Error of Various Training Sets Is Significantly Different
Within and Between Training Sets. 400 week training sets provided the worst
performance. There was no significant difference between using 540 week and 700
week training sets. There was significant differences between training sets that
included the 2009 pandemic and those that did not.
Training Set
Prediction Error (MAE)
Week 1 Week 5 Week 10
Weeks 100 - 500 0.6630 0.6637 0.6664
400 Weeks Weeks 200 - 600 0.5370 0.5274 0.5394
Weeks 300 - 700 0.3374 0.6682 0.6440
0.5124 0.6197 0.6166
Weeks 0 - 540 0.3103 0.4678 0.5792
540 Weeks Weeks 0 - 270 & 540 - 806 0.3860 0.5399 0.5563
Weeks 270 - 806 0.3130 0.3609 0.3878
0.3364 0.4562 0.5077
Weeks 0 -700 0.5227 0.5806 0.7309
700 Weeks Weeks 53 - 753 0.3086 0.6008 0.6094
Weeks 106 - 806 0.4263 0.6601 0.5861
0.4192 0.6138 0.6421
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predictions, they were removed one by one. The data set became progressively smaller
until only data columns ’percent ILI’, ’Week’ and ’Year’ remained. Temperature was
the most important variable for predicting Week 1. Precipitation also had a significant
effect when removed. Removing either of these variables reduced performance of week
1 predictions. Removing population and vaccination data appears to have improved
predictive power substantially. Removing temperature and monthly precipitation,
weekly precipitation and weekly temperature decreased predictive performance. The
best predictions were obtained with a data set containing only precipitation and
average temperature (4.2).
Table 4.2 Temperature Is the Strongest Predictor for ILI. Parameters were removed
one by one in descending order. Models were trained on weeks 0–540 and tested on
weeks 541–806.
Parameter Prediction Error (MAE)
Base Model 0.213
Average Wind Speed - Monthly 0.182
Precipitation - Monthly 0.218
Average Temperature - Monthly 0.204
Population 0.195
Vaccine Effectiveness 0.195
Vaccination Rate 0.187
Average Wind Speed - Weekly 0.163
Precipitation - Weekly 0.185
Average Temperature - Weekly 0.231
4.3 Comparing Standard and Recursive Predictions
Once baseline performance was established, standard predictions could be compared
to recursive predictions. Predictions using the standard model and a time lag of one
week was used as a baseline for evaluation. Time lags of 4, 12, 16 and 52 weeks using
the standard model were compared to baseline. A time lag of 4 weeks provided an
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average decrease of 0.1400 percent ILI error across weeks 1, 5 and 10. The greatest
improvement was seen in week 10 predictions. Week predictive performance degraded
as the time lag increased past 4 weeks (4.3).
A. B.
C.
Figure 4.2 ILI predictions accuracy varies with time lag and prediction method.
Using a recursive function with a 4 week time lag provided the most balanced
predictions. Week 1 predictions compare well with label data. The predictive
accuracy drops off as predictions range further out, however they remain better than
alternative methods (A). Reducing time lag using recursive predictions causes under
prediction across the entire prediction range (B). The baseline model using a 1 week
time lag produces good 1 week predictions that rapidly degrade over the range of
predictions (C). All predictions were made using a model trained on weeks 0–540 and
tested on weeks 541–806. Predicted values are percent weighted ILI. Data plotted here
has been standardized resulting in negative values on the y-axis. NOTE: Predicted
values are offset due to plotting based on prediction start week, thus peaks for week
10 predictions appear slightly delayed.
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Table 4.3 A 4 Week Time Lag Provides Best Predictive Performance. Increasing
time lag degraded week 1 prediction performance using the standard model but
improved week 5 prediction performance. Using a 4 week time lag increased overall
performance of the recursive model vs. baseline
Time Lag
Prediction Error (MAE)
Week 1 Week 5 Week 10
Baseline 0.3412 0.4485 0.4963
t-4 0.2903 0.2882 0.2876
t-12 0.4000 0.4867 0.4709
t-16 0.3831 0.4592 0.4496
t-52 0.4838 0.5127 0.4868
4.4 Predicting Outlier Years
When outliers were removed from training data, predictive power was reduced
in a regular way. The Premoved model was unable to predict outlier years with
the same accuracy as the Pincluded model. Notably, there was an extremely large
discrepancy when predicting the 2003-2004 flu season (4.4). Further testing to
identify outlier signals showed that there may be consistently reduced performance.
10 week predictions provided the largest divergence in predictions.When two models
were compared on the test data set containing weeks 540 - 806, a small signal was
evident(4.3). However, the signal is very noisy.
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Figure 4.3 Two models trained on different data sets may provide a usable signal for
identifying outlier flu years. Measuring divergence between two alternatively trained
models provides a weak signal indicting possible outlier years. Week 10 predictions
contained the largest error but also contained the largest systematic divergence,
despite noise. Models trained on weeks 0 - 540 (approximate due to outlier removal)
and tested on remaining weeks. Predicted values are weighted percent ILI. Data
plotted has been standardized resulting in negative values on the y-axis.
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Figure 4.4 Removing outliers from training data set produces large prediction
error in test outlier years. When trained on weeks 270 to 806 (approximately) models
produce large prediction errors compared to models trained on complete data sets.
Models trained on weeks 270 - 806 with and without outlier years. Predicted values
are weighted percent ILI. Data plotted has been standardized resulting in negative
values on the y-axis.
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CHAPTER 5
DISCUSSION
Influenza produces seasonal outbreaks that have large economic and human costs.
Currently, our best defense against seasonal outbreaks is widespread vaccination.
However, despite advances in virology, epidemiology and immunology, a perfect
influenza vaccine has eluded researchers. Additionally, major pandemic seasons can
occur unexpectedly. As a result, predicting when and how any given flu season
progresses is of the utmost importance. Early warning can allow development of
targeted vaccines and health service preparation. To that end, a model predicting
weekly percent ILI was developed.
The model made use of an LSTM-based neural network. By treating flu data
available from the CDC as a time series, useful predictions were made. To increase
predictive performance, climate and population data was added to the training set.
By manipulating training sets and training variables, we were able to draw several
conclusions.
5.1 Climate, Especially Temperature is an Important Predictor in
Temperate Regions
Temperature was the strongest climate predictor that was used. Removing temperature
data resulted in a sharp decline in predictive performance. This model suggests that
there is at least a correlation between temperature and ILI rates. However, it provides
no insight as to why this correlation exists. Precipitation was also a significant
predictor, although to a lesser degree. This may be a result of precipitation’s
correlation with humidity. So, in this case, precipitation may be acting as a partial
proxy for humidity data. Although the actual effect of relative humidity on influenza
virus transmission has been contested, its usefulness as a predictor in modeling
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remains unchanged. Thus, the use of precipitation in place of less uniform humidity
data may be of some benefit for future models. Notably, adding future climate data
to the model greatly improves predictive performance. With unlimited future climate
data, predictions may be pushed much further past the 10 week limit seen in this
thesis. However,this is likely not realistic given current meteorological predictions.
Including climate data in influenza models provides a measurable increase in
predictive power. However, climate data can be difficult to gather. In this case, select
weather stations were used and the data averaged to create regional approximations.
It is possible that if the model was applied to a smaller geographical area with
more uniform weather, the predictive effect of climate data may be even greater.
Future effort may be dedicated to collecting higher quality climate data from other
sources. More granular data seemed to have a larger effect than less granular data.
Weekly averages derived from daily data had a larger impact than weekly averages
derived from monthly data. However, monthly data may be sufficient in some cases.
Investigating the relationship between weekly influenza rates and the time-step of
climate data may provide an insight into how and why climate effects influenza.
5.2 Population and Vaccination Data May Not Be Relevant to
Modeling Using LSTM-Based Models
Removing population and vaccination data had no effect and increased performance,
respectively. While this may indicate that these factors are not useful predictors,
it is more likely that the data available was not sufficient. The data structure may
have been inadequate to reveal underlying patterns. The population data used in
this thesis was limited to regional total populations and the vaccination data was
limited to national data. If more specific, granular data could be collected, it may be
extremely useful in predicting influenza. However, due to the variability in flu vaccine
effectiveness it is unlikely to be a useful predictive tool. Yearly effectiveness can only
be calculated retrospectively. Despite the the lack of impact of population data, it
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would likely be much more valuable when adding a spacial dimension to the model,
although that is outside of the scope of this thesis.
5.3 Training Sets Matter
Depending on the training set, the ability to predict changed. To an extent, more
data provides better predictions. However, in a similarly tuned model, the optimal
training set seemed to be about 10 years or about 540 weeks. This translates to about
two-thirds of the total data set. Due to the time scale of yearly trends, some patterns
may not be apparent in the limited data set. Whether or not the model is able to
identify these hidden patterns is difficult to know. This is a potential downside of
using a machine learning approach. For the most part, the model is very opaque.
Without the ability to understand exactly what the model is learning, the best way
to test generalizability is to rotate training data, taking different windows of data.
The inclusion or exclusion of certain years certainly affects the predictive power.
This may indicate an underlying pattern that is better represented in some years
rather than others. It may also indicate patterns that are better represented by sets
of years, implying that the large sequence of years is as important as the granular data.
Unfortunately, as mentioned previously, limited data prevents further investigation
of this problem.
A specific example of variability in training data is the exclusion of the 2009
pandemic year. Models including this year in training data were able to better predict
testing data than those without. This may indicate a robust pattern that emerges
when the 2009 season is included. More data is needed to expand the scope of the
model and understand more about the driving factors. Unfortunately, older CDC
data is incomplete and more difficult to manage. Thus, previous pandemic years
are not readily available for inclusion. A specific effort to collect and complete the
data would be needed before it could be applied to this model. Of course data is
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continuously added as time advances. As subsequent years can be collected, patterns
may emerge and the model can be reevaluated. However, observing the difference
between models trained with and without outlier years may provide a useful tool for
alternative approaches to prediction.
5.4 Outlier Years May Be Identified Using Prediction Divergence
Given the limits in predicting the myriad of variables that influence influenza
trends, combined with the fact that many drivers of seasonal influenza are not well
understood, accurate weekly predictions further than several weeks seems unlikely.
Using the difference in predictive performance between models trained with and
without outlier years may significantly extend the usefulness of this model. When
compared to other forecasting techniques, such as those entered in the annual CDC
Flu-Casting competition, this model performs well. However, no direct quantitative
comparison was made in the course of this thesis.
The model put forth by this thesis is easily implemented and extendable to
a variety of experiments. So training two parallel models is quick and requires only
minor data modification. When comparing the results of alternatively trained models,
systematic differences in predictive ability are observed. Specifically, years with
unusually high percent ILI, when removed, cause poor prediction of high incidence
years.
Limited examples of outlier years exist in the current data set. This limits
further exploration of this phenomenon. Additionally, definition of outlier years was
arbitrary. A peak standardized ILI of 4% was chosen. Years that fell slightly below
this threshold may include useful data. With more data, trends may be more clear
and categories may be easier to select. Another potential pitfall is the time-series
nature of the data. Removing individual years may have unknown affects on training.
However, given that the Premoved model predicted all years except outlier years were
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predicted equally as well as the Pincluded, this is unlikely. Again, only a larger data
set could answer this definitively. Despite these problems, the main advantage of this
outlier detection approach is that is can function with the limited data available and
make use of predictions that may be too inaccurate for direct use.
5.5 LSTM-Based Models Provide a Useful Tool for Influenza Prediction
Applying machine learning to biological and epidemiological questions is a relatively
new approach. There has been limited examination of LSTM neural networks as
the basis for influenza tracking models. Good one week predictions show that this
approach is practical for so called now-casting. Also, using a variety of techniques,
including recursive predictions, models can be stretched to predict to an indefinite
point in the future. However, predictive performance plateaus between 5 and 10
weeks out and so is limited.
The primary advantage of this model is the straightforward architecture. It is
small and does not require a vast amount of computational power, although it is much
faster when GPU accelerated. Once the model has been designed and implemented,
new data can be continuously fed. This model could be set up to automatically extract
climate and influenza data in real time from various sources. A simple pre-processing
pipeline would allow the data to be added seamlessly. This would allow relatively
low effort predictions. Additionally, this architecture may be applied to a variety
of locals. Further testing would be needed to confirm generalizability, though. If
the model proves generalizable, it could provide a useful tool for modeling influenza
for smaller organizations with limited resources. This model also provides a solid
framework for future research. Training and prediction time is short, which allows
rapid testing and on the fly modifications.
Overall, the effectiveness of LSTM-based models as a predictive tool is
supported by the results of this thesis. While machine learning may act as a ”black
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box” with opaque inner workings, continuing to apply it to biological questions can
provide a useful practical tool as well as reveal previously unknown patterns in a
system. Prediction of ILI trends using machine learning may have wider implications
for epidemiology. This model and these techniques could be effectively applied to
almost any infectious disease that acts in a time-dependant fashion. With minor
modifications to data processing, the model may be applied to smaller time-scale
outbreaks as long as previous data exists.
Diverging predictions can also provide a novel approach to compensating for
limited data sets. The overall predictive accuracy does not need to be especially
high. Instead, models must vary in predictive performance in a regular way. In cases
where this holds true, this approach may provide a low-bar-of-entry approach for
determining specific outbreak severity well in advance of other modeling techniques.
5.6 Future Research
Moving forward, this model can be further tuned. By manipulating the model, a
better understanding of the underlying mechanisms may be had. The model may
be simplified and studied in depth. Or the model may be used as a base for further
expansion. For example, this model may be readily applied to an automatically
updated web-based system. While this would not provide insight into the driving
factors of influenza trends, it would provide a continuous stream of current data and
updated models. Over the next several years, patterns may become more apparent.
Greater amounts of data are not always useful for increasing model accuracy,
but better data could provide a measurable improvement. Climate data, especially,
provides a large amount of room for improvement. Potentially using more stations,
or better selected stations may provide better correlated data. Looking at areas with
more uniform weather patterns could alleviate this issue. So, a future experiment
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may look at a single state, county or even city. Narrowing the area of interest may
allow for better climate data.
Improving population data also provides room for further exploration. A study
using the lessons learned from this model could add a spacial dimension to forecasting.
By adding another dimension to the analysis, trends that were previously hidden
may become apparent. Specifically, with the advent of effective image recognition,
integration of heat-map type images could allow for straightforward addition of
population density data as well as travel and immigration data. This type of modeling
could be applied to almost any other transmissible disease.
In addition to better integrating population data to provide spacial under-
standing, flu sub-typing data may also be included. In this thesis, sub-type data
was not included because data collection was sporadic and inconsistent year to year.
More complete sub-typing data may lead to useful discoveries. Evaluation of this
is outside the scope of this thesis. The model produced here does provide a usable
framework for such an evaluation, though. Additionally, age data was not evaluated
using this model, although the data was available and the architecture would allow
for inclusion.
5.7 Final Thoughts
In conclusion, this thesis has shown that an LSTM-based model for predicting ILI
trends is practical. The model produces usable results out to 10 weeks, further than
required by the CDC competition on flu forecasting. Predictions past 10 weeks
were not viable and so, by extending time of predictions, this model may reveal
an outer limit for forecasting. Also, by expanding the data set, climate data has
been confirmed as being a useful predictor. Specifically, this is the first LSTM-based
model to incorporate climate, population and vaccination data. Furthermore, by
manipulating the training data, systematic variations in predictions may be seen.
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Using this, a simple system for identifying potential outlier flu years can be created.
The work done for this thesis lays the foundation for a potentially novel approach to
influenza forecasting.
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APPENDIX A
SUPPLEMENTAL DATA, SAMPLE CODE & NETWORK
ARCHITECTURES
This appendix contains select code, model architecture and links to complete data
sets. The complete supplemental material can be found online.
A.1 Data
Complete data used is available online.
CDC influenza data: https://gis.cdc.gov/grasp/fluview/fluportaldashboard.html
NOAA climate data: https://www.ncdc.noaa.gov/data-access/land-based-station-
data/land-based-datasets US Census population data: https://www.census.gov/data.html
A.2 Code Samples
This sample code contains the final model architecture used. The model was build
using a Keras sequential model. The model is then wrapped in a simple function to
compile and output the model for training. This model function is flexible enough
to accept several data and label structures and so does not require modification to
adjust time-step, output or other data structure changes. Code for previous iterations
of this model is available online.
1000
#de f i n e wrapper func t i on f o r model c r e a t i on
1002 de f bui ld modelE ( data , l a b e l s ) :
# data and l a b e l s must be pre−formatted as 3−D arrays with
even
1004 # time−s t ep s . Time s t ep s corre spond ing to one week
# one were chosen
1006
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# take sample s i z e f o r input . cu r r en t l y s e t to one
1008 # samples = data . shape [ 0 ]
# time s t ep s and f e a t u r e s taken from data shape to
1010 # s imp l i f y bu i l d i ng model
# t ime s t ep s = data . shape [ 1 ]
1012 # f e a t u r e s = data . shape [ 2 ]
#output shape based on provided l a b e l data
1014 i f l en ( l a b e l s . shape ) == 2 :
l ab e l s hape = l a b e l s . shape [ 1 ]
1016 e l s e :
l ab e l s hape = 1
1018
# main model
1020 model = keras . Sequent i a l ( [
keras . l a y e r s . B i d i r e c t i o n a l ( l a y e r s .LSTM(500 ,
1022 r e tu rn s equence s=True ,
batch input shape=(( samples ,
1024 t ime s teps , f e a t u r e s ) ) ) ,
merge mode=’ concat ’ ) ,
1026 keras . l a y e r s . B i d i r e c t i o n a l ( l a y e r s .LSTM(500 ,
dropout =.3 ,
1028 r e tu rn s equence s=True ) ,
merge mode=’ concat ’ ) ,
1030 keras . l a y e r s . B i d i r e c t i o n a l ( l a y e r s .LSTM(500 ,
dropout =.3) ,
1032 merge mode=’ concat ’ ) ,
keras . l a y e r s . Dense ( l ab e l s hape )
1034 ] )
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1036 #uses mean abso lu t e e r r o r as l o s s func t i on
model . compi le ( l o s s=’mse ’ ,
1038 opt imize r=t f . keras . op t im i z e r s .Adam( ) ,
met r i c s=[ ’mae ’ , ’mse ’ , R square ] )
1040 re turn model
Listing A.1 Final model architecture.
The code section below contains the function that allows for 10 week predictions
with a 4 week time lag. This was one of the main functions used to evaluate the
models. Complete code, including wrapper functions for other prediction strategies,
is available online.
1000
#
1002 de f p r e d i c t f u t u r e t 4 (model , data ) :
# r e c u r s i v e p r ed i c t i on by week with 4 week lag
1004
# model − t r a in ed model to be used to make p r e d i c t i o n s .
Should
1006 # pred i c t 1 week forward and conta in 4 week time lag
1008 # data − t e s t i n g data . This data should be pre−formatted in
the same
# way as the t r a i n i n g data
1010
1012 # i n i t i a l i z e numpy array to hold p r e d i c t i o n s
# f u l l p r e d i c t i o n s = np . empty ( ( data . shape [ 0 ] , 1 0 ) )
1014
# main loop o f p r ed i c t i on
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1016 # loops p r e d i c t i o n s over each time step ( in t h i s case each
week )
f o r j in range (0 , data . shape [ 0 ] ) :
1018
1020 # i n i t i a l i z e a numpy array o f z e r o s to
# s t o r e p r e d i c t i o n s
1022 p r ed i c t i o n s = np . z e ro s ( ( 10 , 1 ) )
1024 # copy data to ed i t
ed i t da t a = data . copy ( )
1026
# secondary loop that p r ed i c t s 10 weeks out from each
time
1028 # step
f o r i in range ( j , j +10) :
1030 #s t a r t with a 2 week s l i c e o f data
#grow as more i s p r ed i c t ed
1032 base week = ed i t da t a [ : i +1]
1034 #generate p r ed i c t i on on data
pred i c t week = model . p r ed i c t ( base week )
1036
#loop p r e d i c t i o n s back in to data
1038 #[ row , 3 rd dimension == 0 , column ]
1040 #t−1
i f i+1<data . shape [ 0 ] :
1042 ed i t da t a [ i +1 ,0 ,41]= pred i c t week [−1]
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#t−2
1044 i f i+2<data . shape [ 0 ] & i−j>=1:
ed i t da t a [ i +2 ,0 ,28]= pred i c t week [−1]
1046 #t−3
i f i+3<data . shape [ 0 ] & i−j>=2:
1048 ed i t da t a [ i +3 ,0 ,15]= pred i c t week [−1]
#t−4
1050 i f i+4<data . shape [ 0 ] & i−j>=3:
ed i t da t a [ i +4 ,0 ,2]= pred i c t week [−1]
1052
#add p r ed i c t i on to p r ed i c t i o n l i s t
1054 p r ed i c t i o n s [ i−j , ] = pred i c t week [−1 , ]
1056 p r ed i c t i o n s = p r ed i c t i o n s . f l a t t e n ( )
p r e d i c t i o n s = np . reshape ( p r ed i c t i on s , (1 , 10 ) )
1058
# simple add−on to p r in t s t a tu s o f p r e d i c t i o n s
1060 j number = j+1
pr in t ( ”{ j num}/{number}” . format ( j num=j number ,
1062 number=data . shape [ 0 ] ) ,
end= ” ” , f l u s h=True )
1064 f u l l p r e d i c t i o n s [ j , ] = p r ed i c t i o n s [ 0 , ]
1066 re turn f u l l p r e d i c t i o n s
Listing A.2 Select code for recursive and standard predictive functions.
A.3 Model Architecture
1000
59
de f bui ld modelE ( data , l a b e l s ) :
1002 #take sample s i z e f o r input . cu r r en t l y s e t to one
samples = data . shape [ 0 ]
1004 # time s t ep s and f e a t u r e s taken from data shape to s imp l i f y
# bu i l d ing model
1006 t ime s t ep s = data . shape [ 1 ]
f e a t u r e s = data . shape [ 2 ]
1008 #output shape
i f l en ( l a b e l s . shape ) == 2 :
1010 l a b e l s hape = l a b e l s . shape [ 1 ]
e l s e :
1012 l a b e l s hape = 1
1014
model = keras . Sequent i a l ( [
1016 keras . l a y e r s . B i d i r e c t i o n a l ( l a y e r s .LSTM(500 ,
r e tu rn s equence s=True ,
1018 batch input shape=(( samples , t ime s teps ,
f e a t u r e s ) ) ) ,
merge mode=’ concat ’ ) ,
1020 keras . l a y e r s . B i d i r e c t i o n a l ( l a y e r s .LSTM(500 ,
dropout =.25 , r e tu rn s equence s=True ) ,
1022 merge mode=’ concat ’ ) ,
keras . l a y e r s . B i d i r e c t i o n a l ( l a y e r s .LSTM(500 ,
1024 dropout =.25) ,merge mode=’ concat ’ ) ,
keras . l a y e r s . Dense ( l ab e l s hape )
1026 ] )
1028
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#uses mean abso lu t e e r r o r as l o s s func t i on
1030 model . compi le ( l o s s=’mse ’ ,
opt imize r=t f . keras . op t im i z e r s .Adam( ) ,
1032 metr i c s=[ ’mae ’ , ’mse ’ , R square ] )
r e turn model
Listing A.3 Code for final model architecture.
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